{"prompt": "['Study Number: GSP 301-305', 'Version 3.0', 'Date 18-Jul-2018', 'APPENDIX 2. LIST OF CONTACT DETAILS', 'Additional information and contact details related to the study will be provided to each clinical', 'site separately in relevant documents and procedural manuals.', 'SAE and Pregnancy Reporting:', 'Fax:', 'Email:', 'Medical Monitor (Chiltern):', 'Medical Officer', 'Chiltern, a Covance company', '1016 West Ninth Avenue', 'King of Prussia, PA 19406', 'Mobile:', 'Email:', 'Medical Monitor (Glenmark):', 'Vice President, Clinical Sciences-Respiratory', '461 From Road, Paramus, NJ 07652, USA', 'Office:', 'Mobile:', 'Email:', 'Glenmark', 'CONFIDENTIAL', 'Page 77 of 90']['Study Number: GSP 301-305', 'Version 3.0', 'Date 18-Jul-2018', 'APPENDIX 3. PEDIATRIC RHINOCONJUNTIVITIS QUALITY OF', 'LIFE QUESTIONNAIRE (PRQLQ)', 'General Instructions:', '1. A paper version of interviewer-administered PRQLQ will be provided to subjects.', '2. Subjects should be placed in a quiet room to fill out the PRQLQ.', '3. All parents/guardians/caregivers/friends/relatives should be asked to wait in a separate', 'room.', '4. Clinical coordinator/study site personnel (interviewer) will administer this questionnaire.', '5.', 'Additional instructions/guidelines will be provided to each site that needs to be followed', 'for the proper administration/completion of PRQLQ.', 'Specific Instructions for the Clinical Coordinators/Site Personnel Administering the', 'PRQLQ:', 'The PRQLQ administration must be the first procedure conducted at these study visits. After the', 'completion of the PRQLQ, the completed questionnaire should be reviewed to ensure that all', 'questions have been answered.', 'The clinical staff must:', '1. Ask the questions exactly as worded in the questionnaire. Do not skip words or try to', 'simplify or change the questions. Above all, never attempt to paraphrase or revise', 'the', 'questions.', '2. Never \"help\" the subject choose the answer.', \"3. Be neutral in your response to the child's answer.\", '4.', 'Ask subjects about impairments that they have experienced during the last week as a', 'result of their rhinoconjunctivitis.', '5. Parents/guardians/caregivers must not be present at the interview.', '6. Be looking at the child during the interview.', '7. Follow additional instructions/guidelines that will be provide to each site for proper', 'administration/completion of the PRQLQ.', 'Glenmark', 'CONFIDENTIAL', 'Page 78 of 90']['Study Number: GSP 301-305', 'Version 3.0', 'Date 18-Jul-2018', 'PAEDIATRIC RHINOCONJUNCTIVITIS', 'QUALITY OF LIFE QUESTIONNAIRE', '(PRQLQ)', 'INTERVIEWER-ADMINISTERED', '. 1998', 'QOL TECHNOLOGIES LTD.', 'For further information:', 'Elizabeth Juniper, MCSP. MSe', 'Professor', '20 Marcuse Fields', 'Bosham', 'West Sussex', 'PO18 8NA. UK', 'Telephone: + 44 (0) 1243 572124', 'Fax: + 44 (0) 1243 573680', 'Development and validation', 'E-mail: juniper@goltech.co.uk', 'supported by', 'www: http://www.goltech.co.ut', 'HOECHST MARION ROUSSEL', 'The PRQLQ is copyrighted. It may not be altered, sold (paper or', 'C', 'electronic), translated or adapted for another medium without the', 'permission of Elizabeth Juniper.', 'MARCH 2000', 'Glenmark', 'CONFIDENTIAL', 'Page 79 of 90']\n\n###\n\n", "completion": "END"}